Showing 821-830 of 1402 results for "".
Slow AMD Progression
https://modernod.com/topics/retina/slow-amd-progression/38529/Early detection continues to be essential in preserving patients’ vision.New Pharmacotherapeutics for the Treatment of Glaucoma: Targeting the Trabecular Meshwork
https://modernod.com/topics/glaucoma/new-pharmacotherapeutics-for-the-treatment-of-glaucoma-targeting-the-trabecular-meshwork/38048/Current and Future Glaucoma Management: An Update on Existing Options and the Therapeutic Pipeline
https://modernod.com/topics/glaucoma/current-and-future-glaucoma-management-an-update-on-existing-options-and-the-therapeutic-pipeline/37954/Improve Your Bottom Line With Dry Eye Offerings
https://modernod.com/topics/ocular-surface/improve-your-bottom-line-with-dry-eye-offerings/39012/Tap into a variety of exciting clinical solutions to grow your practice.Aberrations in Refractive Cataract Surgery
https://modernod.com/topics/cataractrefractive-surgery/aberrations-in-refractive-cataract-surgery/38896/Remember that good vision is as much about quality as it is about quantity.MIGS for the Modern Optometrist
https://modernod.com/topics/glaucoma/migs-for-the-modern-optometrist/38551/The field is evolving rapidly.Glioblastoma Multiforme
https://modernod.com/topics/neuro-optometry/glioblastoma-multiforme/38437/Recognizing key symptoms and obtaining a detailed history and diagnostic testing can help save a patient’s sight—or even their life.Keratoconus and the CXL Story
https://modernod.com/topics/technology/keratoconus-and-the-cxl-story/38005/An overview of the role of the corneal strengthening procedure in managing this ocular disorder.New Drugs and Delivery Options in Glaucoma
https://modernod.com/topics/glaucoma/new-drugs-and-delivery-options-in-glaucoma/38069/Many are in development.Unlock Your Leadership Potential: See and Inspire Beyond the Lens
https://modernod.com/topics/business/unlock-your-leadership-potential-see-and-inspire-beyond-the-lens/38962/Highlights from a recent YoungOD Connect mentoring session.